EMA image

EMA waves through a raft of drug recommendations

June 26, 2015
Research and Development, Sales and Marketing AbbVie, Alexion, CHMP, EMA, Novartis, Novo Nordisk, brett wells

The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency has recommended several treatments for marketing …

Valeant image

Valeant looking to buy Zoetis

June 26, 2015
Sales and Marketing Actavis, Allergan, Valeant, Zoetis, brett wells

Canadian drugmaker Valeant Pharmaceuticals has made a move to acquire animal health company Zoetis. This is according to the Wall …

Lilly image

UK Court weighs in on Lilly-Actavis Alimta case

June 26, 2015
Medical Communications, Sales and Marketing Actavis, Alimta, UK, lilly

Actavis will be infringing Lilly’s patent if it were to produce generic versions of Alimta, the UK Court of Appeal …

frances_beves

Hanover names branding and comms lead

June 26, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Hanover, frances beves

London-based healthcare communications agency Hanover has recruited Frances Beves as a director to join in August.  Beves joins as a …

kimberly_santiago1

Red Door Unlimited hires new director

June 25, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Kimberly Santiago, Paradigm Communications, Porter Novelli, red door unlimited

Red Door Unlimited has appointed a new director in Kimberly Santiago who joins from Porter Novelli’s sister agency Paradigm Communications.  …

Lilly image

Lilly and Novartis face legal challenges

June 25, 2015
Medical Communications, Sales and Marketing Gleevec, Glivec, Novartis, cymbalta, imatinib, lilly, zyprexa

Judges in California have ruled that Lilly should face claims it failed to fully disclose the extent of post-withdrawal side …

Astrazeneca image

Senior heads depart AstraZeneca and Takeda

June 25, 2015
Medical Communications, Sales and Marketing AstraZeneca, Briggs Morrison, François-Xavier Roger, James Ward-Lilley, Takeda, brett wells

AstraZeneca vice president James Ward-Lilley and Takeda’s chief financial officer François-Xavier Roger are both exiting their respective companies and moving …

marylin_mermod_schule

Sophia Genetics appoints chief financial officer

June 25, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Marylin Mermod Schule, Sophia Genetics

Swiss-based Sophia Genetics that deals in data driven medicine has appointed Marylin Mermod Schule to be its chief financial officer. …

Sovaldi image

China rejects Gilead’s Sovaldi patent

June 24, 2015
Research and Development, Sales and Marketing China, Gilead, hep C, sofosbuvir, sovaldi

Manufacturer of the blockbuster hepatitis C treatment Sovaldi Gilead has seen its application for a patent in China rejected following …

NICE asks for more evidence from dry eye treatment maker

June 24, 2015
Research and Development, Sales and Marketing Ikervis, NHS, NICE, ciclosporin, santen pharma

A NICE appraisal committee has asked for more information on a treatment for chronic dry eye syndrome, after failing to …

google image

Google unveils its health wearable

June 24, 2015
Medical Communications, Sales and Marketing Apple, brett wells, fitbit, gogle x, google, researchkit, study kit, wearable

Google has developed a health-tracking wearable that is not for the consumer market but rather designed to be utilised in …

jon_rees

OBN chief executive Jon Rees steps down

June 24, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing OBN, jon rees, ross sommerville

UK life sciences membership organisation OBN has confirmed that its chief executive Jon Rees is stepping down in August after a decade …

screen_shot_2015-06-23_at_08

Former Sanofi chief executive joins Waypoint

June 23, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Sanofi, Viehbacher, waypoint

The former Sanofi chief executive Christopher Viehbacher is joining Geneva-headquartered business enterprise firm Waypoint Capital as a managing partner.

Pfizer acquires meningitis vaccines from GSK

June 23, 2015
Sales and Marketing GSK, Mencevax, Nimenrix, Novartis, Pfizer, meningitis

Pharma giants GSK and Pfizer have announced an agreement to transfer the ownership of two meningitis vaccines from GlaxoSmithKline to …

NICE reworks cancer guidance for GPs

June 23, 2015
Sales and Marketing Cancer, GPs, NICE, UK, baker, research

The National Institute for Health and Care Excellence says thousands of lives will be saved each year if GPs and …

martin_birkhofer

NuCana appoints chief medical officer

June 23, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing martin birkhofer, nucana

Scottish clinical stage biopharma firm Nucana has appointed Dr Martin Birkhofer as its chief medical officer. Birkhofer, an oncologist by training, …

Google image

Google backs Oxford Sciences Innovation

June 22, 2015
Medical Communications, Sales and Marketing Oxford, Oxford Sciences Innovation, google, ventures

Google has invested into a company that funds spinoffs from Oxford University’s technology and science departments called Oxford Sciences Innovation …

Eisai image

Eisai earns FDA nod for Fycompa

June 22, 2015
Sales and Marketing Eisai, FDA, Fycompa

The FDA has expanded the patient groups for whom Eisai’s epilepsy drug Fycompa is available to include people who have …

gci_health_carly_johns_laura_starr

GCI Health makes team changes

June 22, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing GCI Health, caryl johns, claire martin, helen khan, laura starr

Healthcare comms agency GCI Health has promoted Claire Martin to associate director and Laura Starr to associate director and head …

rare_disease_image

Overcoming barriers in rare diseases

June 22, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing BIA, NHS, Shire, bates, government, nps, rare diseases

In recent months the focus on the need to develop new drugs and fund new treatments for rare diseases has …

The Gateway to Local Adoption Series

Latest content